YNWA MIDCO 2 LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

RSM UK Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The activities of the group together with the factors likely to affect its future development, performance and financial position are set out in the Strategic Report. The group has net current liabilities of $22,380,206 (2023: $20,808,477) at the balance sheet date. The group has a loss before tax of $47,646,566 (2023: $14,438,120). The borrowings detailed in note 20 are subject to a number of covenants, measured on a monthly and quarterly basis. Management has prepared detailed forecasts, including covenant forecasts, for 12 months from the date of signing, and having considered the assumptions and conclusions made by management, and the availability of financial resources, the directors are satisfied that the group has adequate resources to continue in operational existence for the foreseeable future, defined as a minimum period of at least 12 months from the date of approval of these financial statements. As such, the Directors continue to adopt the going concern basis of accounting in preparing the annual financial statements.”

Group structure

1. YNWA MIDCO 2 LIMITED · parent
   1. YNWA Bidco Limited 100% · England and Wales · Holding company
   2. Recruitment Store UK Limited 100% · England · Holding company
   3. Barrington James Limited 100% · England · Pharmaceutical recruitment
   4. Barrington James Switzerland GmbH 100% · Switzerland · Pharmaceutical recruitment
   5. Barrington James LLC 100% · United States of America · Pharmaceutical recruitment
   6. Barrington James GmbH 100% · Germany · Pharmaceutical recruitment
   7. Barrington James Japan Ltd 100% · Japan · Pharmaceutical recruitment
   8. YNWA Finco LLC 100% · USA · Holding company
   9. Barrington James (USA) LLC 96% · United States of America · Pharmaceutical recruitment
   10. FJN Group Ltd 100% · England · Pharmaceutical recruitment
   11. Barrington James OSP Ltd 100% · England · Pharmaceutical recruitment
   12. Green Life Science Recruitment Limited 100% · England · Pharmaceutical recruitment

Significant events

• “On 21 June 2024 the group acquired 100% of the issued capital of FJN Group Ltd for total consideration of $2,975,097. The business acquired operates in the United Kingdom. The principal activity of the business acquired is that of pharmaceutical recruitment.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

11

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  -10.6%

  £41,391,249 → £37,003,407

• Cash

  -44.3%

  £4,384,996 → £2,443,564

• Net assets

  -355.7%

  £8,368,547 → -£21,395,782

• Employees

  -3.9%

  255 → 245

• Operating profit

  -340.9%

  -£6,937,844 → -£30,591,202

• Profit before tax

  -230%

  -£10,702,832 → -£35,319,915

• Wages

  +7.4%

  £13,554,962 → £14,553,560

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers